Jeff Winkler, PhD, the Merriam Professor of Chemistry in the School of Arts & Sciences and Ravi Amaravadi, PhD, Associate Professor of Medicine at Penn Medicine, were named inventors on an issued patent describing novel autophagy inhibitors potentially useful in the treatment of cancer therapy. This patented discovery has been licensed as part of the foundational technology portfolio for Pinpoint Therapeutics, a company focused on developing novel cancer treatments, and is already showing encouraging in vivo results.
